These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29426774)

  • 41. Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran.
    Shahcheraghi F; Moezi H; Feizabadi MM
    Med Sci Monit; 2007 Nov; 13(11):BR247-250. PubMed ID: 17968291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy.
    Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR
    J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.
    Angeli P; Guarda S; Fasolato S; Miola E; Craighero R; Piccolo F; Antona C; Brollo L; Franchin M; Cillo U; Merkel C; Gatta A
    Aliment Pharmacol Ther; 2006 Jan; 23(1):75-84. PubMed ID: 16393283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Efficacy and safety of azithromycin prophylaxis of respiratory tract infections in military community].
    Guchev IA; Klochkov OI; Ivanitsa GV; Pervov IuA; Shturmina SM; Rosman SV
    Antibiot Khimioter; 2004; 49(8-9):34-5, 37-42. PubMed ID: 15727144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of dose frequency on the therapeutic efficacies of ciprofloxacin and ceftazidime in experimental Klebsiella pneumoniae pneumonia and septicemia in relation to their bactericidal activities in vitro.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S33-40. PubMed ID: 3325928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
    Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
    Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided prostate biopsy in Thailand.
    Siriboon S; Tiengrim S; Taweemongkongsup T; Thamlikitkul V; Chayakulkeeree M
    Urol Int; 2012; 88(2):187-93. PubMed ID: 22269856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.
    Kádár B; Kocsis B; Tóth Á; Damjanova I; Szász M; Kristóf K; Nagy K; Szabó D
    Acta Microbiol Immunol Hung; 2013 Jun; 60(2):201-9. PubMed ID: 23827751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular analysis of ciprofloxacin resistance and clonal relatedness of clinical Escherichia coli isolates from haematology patients receiving ciprofloxacin prophylaxis.
    van Hees BC; Tersmette M; Willems RJ; de Jong B; Biesma D; van Hannen EJ
    J Antimicrob Chemother; 2011 Aug; 66(8):1739-44. PubMed ID: 21636586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
    Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
    J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae.
    So W; Crandon JL; Nicolau DP
    J Urol; 2015 Aug; 194(2):563-70. PubMed ID: 25637857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Analysis of antibiotic consumption and microorganism resistance changes].
    Galinyte D; Maciulaitis R; Budnikas V; Kubilius D; Varanaviciene B; Vitkauskiene A; Jokimas J; Jodkonis L
    Medicina (Kaunas); 2008; 44(10):751-67. PubMed ID: 19001833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics.
    Jan IS; Hsueh PR; Teng LJ; Ho SW; Luh KT
    J Formos Med Assoc; 1998 Oct; 97(10):661-6. PubMed ID: 9830274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
    Bennett KM; Scarborough JE; Sharpe M; Dodds-Ashley E; Kaye KS; Hayward TZ; Vaslef SN
    J Trauma; 2007 Aug; 63(2):307-11. PubMed ID: 17693828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of ceftazidime and ciprofloxacin on biofilm formation in Proteus mirabilis rods.
    Kwiecińska-Piróg J; Bogiel T; Gospodarek E
    J Antibiot (Tokyo); 2013 Oct; 66(10):593-7. PubMed ID: 23801185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of major antibiotic resistance in Escherichia coli and Klebsiella pneumoniae in Singapore, USA and China using a limited set of gene targets.
    Ginn AN; Wiklendt AM; Zong Z; Lin RT; Teo JW; Tambyah PA; Peterson LR; Kaul K; Partridge SR; Iredell JR
    Int J Antimicrob Agents; 2014 Jun; 43(6):563-5. PubMed ID: 24721234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.